Home About AlpVision News Contact Us
BUSINESS UNITS
  Brand Protection
  Document Security
  Custom Solutions
PRODUCTS
  FDA Compliance
  Cryptoglyph
  FMCG Protection
  Fingerprint
  Krypsos Platform
  Video Watermarking
TECHN. BACKGROUND
  Digital Watermarking
  Founders’ publications
COMPANY
  About AlpVision
  Awards and Certification
  Open Positions
  How to find us
NETWORK
  Sales Representatives
  Integrators
  Partners / Memberships
NEWS ROOM
  News
  Newsletter
  Press Releases
  White Papers
  In the Press
  Events
  Multimedia Clips
 AlpVision SA
 Rue du Clos 12
 CH-1800 Vevey
 Switzerland
 T : +41 21 948 6464
 F : +41 21 948 6465
      
AlpVision WebEx

   

AlpVision Krypsos open platform to combat counterfeits has successfully achieved compliance with the software and quality requirements of the pharmaceutical industry and health authorities.

 

Krypsos is a server-based authentication system including the Cryptoglyph and Hybrid Cryptoglyph packaging covert security solutions as well as other security features such as for instance Fingerprint, the AlpVision detection solution based on intrinsic characteristics of the product. Third party overt coding such as Bar Codes, two dimensional matrix codes or OCR can also be included.

For a major deployment, which will bring covert protection to over a billion products worldwide by first quarter 2008, AlpVision Krypsos successfully passed the FDA 21 CFR Part 11 requirements for Electronic Records and Electronic Signatures (ERES).

The covert security feature is applied using only standard ink and standard printing processes (offset rotogravure, laser, inkjet, etc.). This technique is perfectly in line with the anti-counterfeiting requirements of the FDA Revitalization Act S.1082 for medicines delivered in the USA.

The Krypsos IT solution enables brand products manufacturers to provide their supply chain with a single point of contact for both drug counterfeit detection and genuine product authentication. It also provides valuable logistics data, such as gray market consolidation, and can generate helpful online notifications for mobile commerce.

Krypsos meets FDA 21 CFR Part 11 requirements providing the following functionalities:

Audit trail documentation

Electronic records

Advanced security controls and password protection

Event reporting and notification including: times, actions, users, and more

Central data storage in a single SQL database

Computer Systems Validation (CSV) was performed in compliance with the V Model and the corresponding documentation is available:

Validation Protocol

User Requirements Specifications

Functional Specifications

Design Specifications

Unit & Integration Tests

Installation Qualification

Operational Qualification

Performance Qualification

Validation Report

AlpVision has also a full QA system in place with following available documentation:

Document Management System

Development Standards

Incident, Problem & Change Management

Operational Handbook

AlpVision IT System Management

Backup/Restore, Archival, Retrieval

Network and Security Management

Configuration Management

Risk Analysis and Contingency plan



Please fill in the right hand side form or Contact AlpVision to evaluate how the Krypsos platform can be customized to your own IT and product environment, as well as your Corporate Visual Identity, to protect your branded products worldwide.

 Request free information:
Topic :
Full Name :
Email :
Job Function :
Telephone :
Company :
Employees :
Country :
Comments :
 
 
Cryptoglyph and AlpVision are registered trademarks of AlpVision SA. Fingerprint and Krypsos are trademarks of AlpVision SA.
Home About AlpVision Brand Protection Document Security Custom Solutions News Events Contact Us
© 2001-2010 AlpVision. All Rights Reserved